Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

spironolactone-hydroCHLOROthiazide

spironolactone-hydroCHLOROthiazide
  • Non-formulary
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Aldactazide TABLET, ORAL 25 mg-25 mg, 50 mg-50 mg    
Comments:

Ordered Formulation

Therapeutic Interchange

spironolactone-hydroCHLOROthiazide (Aldactazide)

  • 25 mg-25 mg tablet                                                          

  • 50 mg-50 mg tablet

spironolactone (Aldactone) AND hydroCHLOROthiazide (HydroDIURIL)

  • ONE 25 mg spironolactone tablet PLUS ONE 25 mg hydroCHLOROthiazide tablet

  • ONE 50 mg spironolactone tablet PLUS ONE 50 mg hydroCHLOROthiazide tablet
Last updated: Jun. 29, 2022






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved